Great to see you again.
You’re here because you’ve been prescribed XELJANZ for active psoriatic arthritis after 1 or more tumor necrosis factor (TNF) blockers have been used and did not work well or cannot be tolerated. We'll always be here with information and resources to help you.
Learn about the risks and benefits of treatment, what you may expect and the importance of tracking your symptoms.
CLINICAL TRIAL RESULTS
The efficacy and safety of XELJANZ® (tofacitinib) were tested in 2 studies that involved adult patients with active psoriatic arthritis. Explore the results.
TRACKING YOUR SYMPTOMS
Recording your symptoms in the PsA Journal may be a useful tool to share with your doctor.
TIPS TO REMEMBER
Easy ways to help you remember to take XELJANZ as prescribed by your doctor.
TELL US MORE
The information you provide here will be used by Pfizer and parties acting on its behalf to develop or improve materials related to certain chronic inflammatory conditions and use of XELJANZ.
